Pharma Capital
Showing 40 of 58
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £72.64m £0.34 0.00% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £40.88m £0.16 3.92% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £16.19m £0.20 0.00% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £6.68m £0.75 0.00% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £191.60m £0.32 0.00% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £253.75m £0.54 0.47% ico_glass.png
Amryt_Pharma_59677939c44cb.png Amryt Pharmaceuticals AIM £45.31m £0.22 -13.43% ico_glass.png
angle-logo.png ANGLE plc AIM £26.56m £0.36 -1.39% ico_glass.png
avacta.png Avacta Group Plc AIM £49.59m £0.73 -1.36% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £35.61m £0.77 0.00% ico_glass.png
CALLITAS.png Callitas Therapeutics Inc CSE £0.70m £0.03 0.00% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid Ltd ASX £15.59m £0.01 0.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £1,211.54m £10.52 1.74% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £16.23m £0.05 0.00% ico_glass.png
concepta.png Concepta AIM £11.78m £0.11 0.00% ico_glass.png
Cynata.png Cynata Therapeutics ASX £34.36m £0.38 -3.82% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £9.78m £0.03 8.70% ico_glass.png
e-ther.png e-Therapeutics plc AIM £28.53m £0.11 0.00% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £69.02m £1.70 1.80% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £234.48m £8.40 -2.89% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £32.13m £0.27 0.00% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £6.73m £0.36 0.00% ico_glass.png
imm.gif ImmuPharma PLC AIM £66.92m £0.51 4.66% ico_glass.png
ID_LOGO.png InnovaDerma LSE £39.80m £3.16 -1.87% ico_glass.png
ixico-logo.png IXICO Plc AIM £8.95m £0.33 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £107.76m £2.48 0.00% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £37.01m £0.76 0.00% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £61.70m £0.32 0.00% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £28.82m £0.42 1.21% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £11.70m £0.02 2.56% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £52.79m £0.67 -0.74% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals Ltd ASX £24.07m £0.24 -2.50% ico_glass.png
Pharmaxis---200x100.jpg Pharmaxis Ltd ASX £52.27m £0.16 -1.82% ico_glass.png
pbi120.jpg Pressure Biosciences Inc OTCMKTS £- £- - ico_glass.png
1505914574_PREVE.png PreveCeutical Medical Inc CSE £7.82m £0.48 5.48% ico_glass.png
au_piqlogo_new120x60.jpg Proteomics International Laboratories ASX £7.68m £0.13 -2.27% ico_glass.png
qbio.png Q BioMed Inc OTCMKTS £- £- - ico_glass.png
redx-logo.png Redx Pharma Plc AIM £40.95m £0.32 -1.52% ico_glass.png
rgs[LOGO]200x100.jpg Regeneus Ltd ASX £18.34m £0.09 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.